Temporary Arterial Embolization of Liver Parenchyma with Degradable Starch Microspheres (EmboCept®S) in a Swine Model

[1] de Baere T(2011)Arterial therapies of colorectal cancer metastases to the liver Abdom Imaging 36 661-670

[2] Deschamps F(2005)Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: factors associated with liver toxicities J Vasc Interv Radiol 16 205-213

[3] Goin JE(2005)Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival J Vasc Interv Radiol 16 1627-1639

[4] Salem R(2013)Chemoembolization of hepatocellular carcinoma Semin Intervent Radiol 30 3-11

[5] Carr BI(2010)Vascular complications of hepatic artery after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma AJR Am J Roentgenol 195 245-252

[6] Dancey JE(2013)Dynamic evaluation and quantification of microvascularization during degradable starch microspheres transarterial chemoembolisation (DSM-TACE) of HCC lesions using contrast enhanced ultrasound (CEUS): a feasibility study Clin Hemorheol Microcirc 53 337-348

[7] Soulen MC(2011)Basic and therapeutic aspects of angiogenesis Cell 146 873-887

[8] Geschwind JF(2013)Transcatheter arterial chemoembolization using cisplatin powder mixed with degradable starch microspheres for colorectal liver metastases after FOLFOX failure: results of a phase I/II study J Vasc Interv Radiol 24 56-65

[9] Salem R(2008)Oily chemoembolization combined with degradable starch microspheres for HCC with cirrhosis Hepatogastroenterology 55 1041-1046

[10] Lewandowski RJ(2014)Feasibility of temporary protective embolization of normal liver tissue using degradable starch microspheres during radioembolization of liver tumours Eur J Nucl Med Mol Imaging 41 231-237

[1] de Baere T(2011)Arterial therapies of colorectal cancer metastases to the liver Abdom Imaging 36 661-670

[2] Deschamps F(2005)Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: factors associated with liver toxicities J Vasc Interv Radiol 16 205-213

[3] Goin JE(2005)Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival J Vasc Interv Radiol 16 1627-1639

[4] Salem R(2013)Chemoembolization of hepatocellular carcinoma Semin Intervent Radiol 30 3-11

[5] Carr BI(2010)Vascular complications of hepatic artery after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma AJR Am J Roentgenol 195 245-252

[6] Dancey JE(2013)Dynamic evaluation and quantification of microvascularization during degradable starch microspheres transarterial chemoembolisation (DSM-TACE) of HCC lesions using contrast enhanced ultrasound (CEUS): a feasibility study Clin Hemorheol Microcirc 53 337-348

[7] Soulen MC(2011)Basic and therapeutic aspects of angiogenesis Cell 146 873-887

[8] Geschwind JF(2013)Transcatheter arterial chemoembolization using cisplatin powder mixed with degradable starch microspheres for colorectal liver metastases after FOLFOX failure: results of a phase I/II study J Vasc Interv Radiol 24 56-65

[9] Salem R(2008)Oily chemoembolization combined with degradable starch microspheres for HCC with cirrhosis Hepatogastroenterology 55 1041-1046

[10] Lewandowski RJ(2014)Feasibility of temporary protective embolization of normal liver tissue using degradable starch microspheres during radioembolization of liver tumours Eur J Nucl Med Mol Imaging 41 231-237